Glimital-M 1 Tablet PR – Anti-Diabetic Medicine for Type 2 Diabetes

Product Introduction
Glimital-M 1 Tablet PR is an advanced prescription medicine designed to manage type 2 diabetes mellitus in adults. It combines two proven anti-diabetic agents—Glimepiride and Metformin—to help regulate blood sugar levels effectively. This dual-action formula works by stimulating insulin release from the pancreas while improving the body’s sensitivity to insulin and reducing glucose production in the liver.

Key Benefits

• Helps control and maintain healthy blood sugar levels in adults with type 2 diabetes.

• Reduces the risk of long-term diabetes-related complications such as kidney damage, eye disorders, nerve damage, and limb loss.

• Promotes better glucose utilization in the body for improved energy balance.

• When combined with a proper diet, regular exercise, and weight management, it supports healthier living with diabetes.

How It Works

• Glimepiride (Sulfonylurea): Increases insulin secretion from the pancreas.

• Metformin (Biguanide): Decreases glucose production in the liver, slows intestinal glucose absorption, and enhances insulin sensitivity.

Usage Instructions
Take Glimital-M 1 Tablet PR with food at the same time each day to maximize its effectiveness. Always follow your doctor’s prescribed dosage. Do not discontinue the medicine without medical advice, as this may cause a rise in blood sugar levels.

Possible Side Effects
Most side effects are temporary and improve as your body adjusts. Commonly reported reactions include:

• Low blood sugar (hypoglycemia) with symptoms like sweating, dizziness, shaking, and headache

• Nausea, diarrhea, or stomach discomfort

• Headache or mild taste changes

• Weight gain or mild upper respiratory infections in some individuals

If side effects persist or become severe, consult your healthcare provider promptly.

Safety Information & Precautions

• Alcohol: Avoid alcohol consumption as it may increase the risk of low blood sugar.

• Pregnancy: Use only if prescribed by a doctor. Potential risks to the unborn child should be assessed by a healthcare professional.

• Breastfeeding: Not recommended due to possible risks to the baby.

• Driving: Low or fluctuating blood sugar may impair concentration; avoid driving if you feel unwell.

• Kidney & Liver Conditions: Not suitable for patients with severe kidney or liver disease. Regular monitoring is advised for those with mild to moderate conditions.

Missed Dose
If you forget a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed one and continue your regular schedule. Do not double the dose.

Product Variants & Keywords

Glimital-M 1 Tablet PR, Glimital M 1 Tablet, Glimital-M Tablet PR, Glimital M PR for Diabetes, Glimital M 1